Tsujimura, S., & Tanaka, Y. (2019). Treatment with Methotrexate and Intravenous Cyclophosphamide Pulse Therapy Regulates the P-gp(+)CD4(+) Cell-related Pathogenesis in a Representative Patient with Refractory Proliferative Lupus Nephritis. Intern Med.
Citación estilo ChicagoTsujimura, Shizuyo, and Yoshiya Tanaka. "Treatment With Methotrexate and Intravenous Cyclophosphamide Pulse Therapy Regulates the P-gp(+)CD4(+) Cell-related Pathogenesis in a Representative Patient With Refractory Proliferative Lupus Nephritis." Intern Med 2019.
Cita MLATsujimura, Shizuyo, and Yoshiya Tanaka. "Treatment With Methotrexate and Intravenous Cyclophosphamide Pulse Therapy Regulates the P-gp(+)CD4(+) Cell-related Pathogenesis in a Representative Patient With Refractory Proliferative Lupus Nephritis." Intern Med 2019.